Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00243022
What this trial is testing

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System TumorsCerebral Edema
Ali Altunkaya 12
Early research (Phase 1)Study completedNCT00385853
What this trial is testing

PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs

Who this might be right for
Glioblastoma
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Looking for participantsNCT06649851
What this trial is testing

G-CSF After Chemo-radiation in Patients With Glioblastoma

Who this might be right for
MGMT-Methylated GlioblastomaGlioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme
Massachusetts General Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07476794
What this trial is testing

Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma

Who this might be right for
Glioblastoma
Sunnybrook Health Sciences Centre 118
Testing effectiveness (Phase 2)WithdrawnNCT00046878
What this trial is testing

Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Very early researchStudy completedNCT04614909
What this trial is testing

Study of Pamiparib in Newly Diagnosed and rGBM

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme, Adult
Nader Sanai 50
Testing effectiveness (Phase 2)Study completedNCT00274833
What this trial is testing

Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
CNS Tumor, Adult
David Peereboom 27
Early research (Phase 1)Study completedNCT00884416
What this trial is testing

Sorafenib in Newly Diagnosed High Grade Glioma

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
University Hospital, Geneva 17
Testing effectiveness (Phase 2)Study completedNCT00003464
What this trial is testing

Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 50
Large-scale testing (Phase 3)Study completedNCT01149109
What this trial is testing

Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients

Who this might be right for
Glioblastoma
University Hospital, Bonn 141
Testing effectiveness (Phase 2)Study completedNCT00262730
What this trial is testing

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 97
Testing effectiveness (Phase 2)Looking for participantsNCT04765514
What this trial is testing

Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients

Who this might be right for
Glioblastoma Multiforme
AHS Cancer Control Alberta 107
Early research (Phase 1)Looking for participantsNCT04732065
What this trial is testing

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Who this might be right for
Diffuse Midline Glioma (DMG)GlioblastomaRecurrent Ependymoma+5 more
Sabine Mueller, MD, PhD 208
Large-scale testing (Phase 3)Study completedNCT00006353
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 575
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862430
What this trial is testing

NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
NuvOx LLC 87
Large-scale testing (Phase 3)Study completedNCT04396860
What this trial is testing

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Who this might be right for
GliosarcomaMGMT-Unmethylated Glioblastoma
National Cancer Institute (NCI) 159
Testing effectiveness (Phase 2)Looking for participantsNCT05734560
What this trial is testing

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Who this might be right for
Newly Diagnosed MGMT Unmethylated Glioblastoma
Darell Bigner 50
Testing effectiveness (Phase 2)UnknownNCT00006460
What this trial is testing

Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365280
What this trial is testing

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
ZSky Biotech Inc 78
Not applicableUnknownNCT02904525
What this trial is testing

Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model

Who this might be right for
Glioblastoma
Andreas Hottinger 20
Next Page